Extended release torsemide: phase 2
Ended Project Grant Awarded Last action
- Award ID
- R44DK098856
- Recipient
-
Sarfez Pharmaceuticals, Inc. UEI YRJBXMC3Y9W6
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,987,476
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Funding agency
- Department of Health and Human Services
- Place of performance
- Virginia, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $1,091,216 | |
| Original award | $896,260 |
Quick answers
Who received award R44DK098856?
R44DK098856 was awarded to Sarfez Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on September 27, 2013.
How much is award R44DK098856 worth?
$1,987,476 has been obligated on R44DK098856.
Which agency awarded R44DK098856?
National Institutes of Health (Department of Health and Human Services) awarded R44DK098856, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award